All these products contribute to the ICD of tumor cells, stimulating the cGAS-STING pathway, activating DCs, increasing T lymphocytic infiltration, and reversing the immunosuppressive microenvironment (shifting from M2 macrophages to M1 macrophages). This evidence concerns the gene CGAS and neoplasm.